Dianthus Therapeutics (DNTH) PT Raised to $131 at Raymond James

August 5, 2026 6:39 AM

Raymond James analyst Ryan Deschner raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $131.00 (from $125.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found